List of insiders holdings for IMMUNE PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Teper Daniel Gedeon CEO 10% Owner | 2016-10-11 18:10:04 | 6,050,753 0 | 6,050,753 | Form 4 |
TVM III Limited Partnership TVM Techno Venture Management No. III Limited Partnership 10% Owner | 2007-02-14 15:22:30 | 4,559,328 0 | 4,559,328 | Form 13G |
TVM IV GMBH & CO KG TVM IV Management GmbH & Co. KG 10% Owner | 2006-01-05 14:33:15 | 3,408,464 0 | 3,408,464 | Form 3 |
Merlin General Partner II LTD Merlin Biosciences Fund L.P. Merlin Biosciences Fund GbR Member 13G Group - see Remarks 10% Owner | 2006-01-04 17:25:12 | 0 2,461,928 | 2,461,928 | Form 3 |
Private Equity Direct Finance 10% Owner | 2006-01-04 17:27:39 | 2,115,343 0 | 2,115,343 | Form 3 |
Kimball Ranch C Director | 2017-02-03 16:02:16 | 1,800,000 0 | 1,800,000 | Form 4 |
Luchi Monica E. EVP & CMO | 2016-08-04 21:41:50 | 777,778 0 | 777,778 | Form 4 |
Kazado Daniel Director | 2017-01-27 19:13:06 | 740,000 0 | 740,000 | Form 4 |
DUNTON ALAN W Director | 2013-08-14 17:38:30 | 705,000 0 | 705,000 | Form 4 |
Paley Jeffrey Director | 2017-01-27 19:15:48 | 700,000 0 | 700,000 | Form 4 |
Durrant Cameron Director | 2017-01-27 19:12:28 | 690,000 0 | 690,000 | Form 4 |
Neczesny John A. Director | 2017-01-27 19:15:03 | 640,000 0 | 640,000 | Form 4 |
Ben-Ami Miri See Remarks | 2016-06-03 16:53:58 | 580,000 0 | 580,000 | Form 4 |
Savage Robert G. Director | 2013-08-14 17:50:02 | 475,300 0 | 475,300 | Form 4 |
ALLARD STEPHANE Chief Medical Officer | 2012-12-28 15:37:21 | 414,180 3,333 | 417,513 | Form 4 |
Brownlie Keith L Director | 2013-08-14 17:45:39 | 360,000 0 | 360,000 | Form 4 |
Tseng Ben Chief Scientific Officer | 2009-01-07 16:49:49 | 329,291 0 | 329,291 | Form 4 |
Militello John See Remarks | 2016-06-03 16:06:24 | 320,000 0 | 320,000 | Form 4 |
Talley John V. President, CEO and Director | 2011-01-19 17:10:19 | 300,000 0 | 300,000 | Form 4 |
Chen Michael VP-Global Business Development | 2009-02-24 20:19:30 | 263,560 0 | 263,560 | Form 4 |
Bedard John F. Director | 2008-07-02 10:14:17 | 249,562 0 | 249,562 | Form 4 |
Maza Elliot M Interim CEO | 2017-07-20 20:52:25 | 162,000 0 | 162,000 | Form 4 |
BHAGWAT DILEEP Senior VP - Pharma. Devel. | 2011-01-19 17:20:15 | 100,000 0 | 100,000 | Form 4 |
Damask Michael C Chief Medical Officer | 2006-07-27 12:40:54 | 100,000 0 | 100,000 | Form 3 |
Cook Robert W. CFO and Senior VP | 2014-02-05 12:36:08 | 100,000 0 | 100,000 | Form 4 |
Berdugo Gad CFO & SVP | 2015-05-12 17:17:30 | 100,000 0 | 100,000 | Form 4 |
SIDRANSKY DAVID Director | 2015-01-12 17:16:36 | 71,699 0 | 71,699 | Form 4 |
De Kergrohen Herve Director | 2013-08-27 17:33:06 | 71,419 0 | 71,419 | Form 4 |
Smyth A. Collier Director | 2012-06-25 11:11:54 | 60,000 0 | 60,000 | Form 4 |
Yetter Wayne P. Director | 2012-06-25 11:19:26 | 60,000 0 | 60,000 | Form 4 |
Waldheim Gerhard Director | 2012-06-25 11:15:44 | 60,000 0 | 60,000 | Form 4 |
Stancic Ana Director | 2015-01-12 17:10:46 | 50,000 0 | 50,000 | Form 4 |
LERER RENE Director | 2015-01-12 17:08:51 | 50,000 0 | 50,000 | Form 4 |
AZRIA RENE PIERRE Director | 2015-09-16 17:17:56 | 50,000 0 | 50,000 | Form 4 |
Jackson Guy C. Director | 2010-06-07 14:30:58 | 35,000 0 | 35,000 | Form 4 |
Albouy Pierre Director | 2013-08-27 17:23:10 | 29,758 0 | 29,758 | Form 4 |
Lockhart Earle VP - Clinical & Reg Affairs | 2006-01-09 16:15:01 | 28,125 0 | 28,125 | Form 4 |
Elefant Dov Controller - VP - Fin & Admin | 2006-01-09 16:13:15 | 28,125 0 | 28,125 | Form 4 |
Wiedemann Oliver see remarks | 2011-01-12 18:28:12 | 25,000 0 | 25,000 | Form 4 |
McClurg Michael VP - Bus Dvlpmnt - Oncology | 2006-01-10 12:25:43 | 20,000 0 | 20,000 | Form 4 |
Clark John P See Remarks | 2018-11-20 09:57:11 | 20,000 0 | 20,000 | Form 3 |
Tyrrell Bernard R Senior VP - Sales & Marketing | 2010-02-12 18:42:29 | 12,500 0 | 12,500 | Form 4 |
Kobrin Isaac Director | 2014-06-25 16:10:55 | 2,400 0 | 2,400 | Form 4 |
Caspritz Gert Director | 2008-10-08 11:59:29 | 0 0 | 0 | Form 5 |
Fiorino Anthony S. Director | 2020-02-04 11:45:53 | 0 0 | 0 | Form 4 |